<DOC>
	<DOCNO>NCT02273492</DOCNO>
	<brief_summary>Comparative pharmacokinetics pharmacodynamics Asasantin ER fast fed state</brief_summary>
	<brief_title>Impact Food Pharmacokinetics Pharmacodynamics Asasantin ER Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<criteria>Healthy subject determine result screen Signed write informed consent accordance good clinical practice ( GCP ) local legislation Age ≥ 18 ≤ 55 year Broca ≥ 20 % ≤ + 20 % Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder Chronic relevant acute infection History hypersensitivity Asasantin ER excipients Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug might influence result trial ( ≤ 10 day prior administration trial ) Participation another trial investigational drug ( &lt; 1 month prior administration trial ) Known alcohol abuse Known drug abuse Blood donation ( &lt; 1 month prior administration ) Excessive physical activity ( &lt; 5 day prior administration ) History hemorrhagic diatheses History gastrointestinal ulcer , perforate bleed History bronchial asthma Any laboratory value outside normal range clinical relevance Female subject : Pregnancy Positive pregnancy test No adequate contraception ( adequate contraception e.g . sterilization , intrauterine device ( IUD ) , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>